| FCLCX | FIKEX | FCLCX / FIKEX | |
| Total Expense Ratio | 1.74 | 0.59 | 295% |
| Annual Report Gross Expense Ratio | 1.74 | 0.59 | 295% |
| Fund Existence | 29 years | 8 years | - |
| Gain YTD | 16.970 | 17.834 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 2.16B | 100% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 19.81 | 21.90 | 90% |
| Returns for 3 years | 64.58 | 77.31 | 84% |
| Returns for 5 years | 31.16 | 50.50 | 62% |
| Returns for 10 years | 57.18 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBE | 97.59 | 1.03 | +1.07% |
| Invesco Biotechnology & Genome ETF | |||
| IQDY | 43.84 | 0.46 | +1.07% |
| Northern Trust Intl Qual Div Dyn ETF | |||
| IWL | 189.35 | 0.74 | +0.39% |
| iShares Russell Top 200 ETF | |||
| ATTR | 95.04 | 0.14 | +0.15% |
| Arin Tactical Tail Risk ETF | |||
| HEQQ | 60.92 | 0.08 | +0.13% |
| JPMorgan Nasdaq Hdg Eq Ldrd Overlay ETF | |||